Wednesday, August 02, 2017 9:09:39 PM
ISODIOL INTERNATIONAL INC. ANNOUNCES OTC SYMBOL CHANGE
The Financial Industry Regulatory Authority Inc. has approved Isodiol International Inc.'s OTC voluntary symbol change from LAGBF to ISOLF to better reflect the company's current name.
The changes will be reflected at the opening of the market on Aug. 3, 2017.
About Isodiol International Inc.
Isodiol International is the market leader in pharmaceutical-grade cannabis compounds and the industry leader in the manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for hemp-derived cannabinoids, microencapsulation and nanotechnology for the highest-quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries, and will aggressively continue international expansion into Latin America, Asia and Europe.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM